Updated on 30 July 2015
Perceptive MyTrials Analytics offers enhanced analytics capabilities and cross-study business intelligence
Singapore: Parexel International has launched the next generation of its Perceptive MyTrials platform with advanced analytics capabilities that allows real-time and aggregated analytics to detect key signals and trends.
With the Perceptive MyTrials Analytics solution, clinical trial sponsors can now use a mobile-enabled, single entry-point to access predictive data analytics for multiple studies simultaneously.
"As clinical studies become more complex, there is a growing need for real-time and standardized data and analytics from multiple studies," said Mr Xavier Flinois, president, PAREXEL Informatics. "Using the enhanced tools available with the Perceptive MyTrials Analytics solution, our clients can visualize trends across studies, garner reliable intelligence, and confidently make data-driven business decisions. This information will ultimately help reduce risk, increase clinical trial efficiency, and speed time to market for our clients and for patients."
Developed by PAREXEL Informatics, the Perceptive MyTrials platform provides an integrated suite of applications for managing clinical trials. Perceptive MyTrials Analytics offers enhanced analytics capabilities and cross-study business intelligence from within the Perceptive MyTrials platform.